Paper17469029
Impact of the degree of hydronephrosis on the efficacy of in situ extracorporeal shock-wave lithotripsy for proximal ureteral calculi.
El-Assmy A and 4 others. Scand J Urol Nephrol, 2007. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Impact of the degree of hydronephrosis on the efficacy of in situ extracorporeal shock-wave lithotripsy for proximal ureteral calculi. Papers, record 17469029. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17469029
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Impact of the degree of hydronephrosis on the efficacy of in situ extracorporeal shock-wave lithotripsy for proximal ureteral calculi.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hydronephrosis | Major topic |
| Lithotripsy | Major topic |
| Ureteral Calculi | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Female | |
| Humans | |
| Kidney | |
| Male | |
| Middle Aged | |
| Prospective Studies | |
| Time Factors | |
| Treatment Outcome | |
| Ultrasonography | |
| Ureter |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39821148 | Impact of hydronephrosis on shockwave lithotripsy outcomes for upper ureteral stones. | Int Urol Nephrol | 2025 | https://conductscience.org/library/papers/39821148 | PubMed |
| 36585472 | Development and validation of a predictive model for treatment outcome after emergency extracorporeal shockwave lithotripsy in patients with symptomatic ureteral stones during the COVID-19 pandemic: in a large prospective cohort. | Urolithiasis | 2022 | https://conductscience.org/library/papers/36585472 | PubMed |
| 35223107 | The effect of stone size on the results of extracorporeal shockwave lithotripsy versus semi-rigid ureteroscopic lithotripsy in the management of upper ureteric stones. | Arab J Urol | 2022 | https://conductscience.org/library/papers/35223107 | PubMed |
| 33210203 | Laser lithotripsy for proximal ureteral calculi in adults: can 3D CT texture analysis help predict treatment success? | Eur Radiol | 2021 | https://conductscience.org/library/papers/33210203 | PubMed |
| 32279108 | Factors affecting success in the treatment of proximal ureteral stones larger than 1 cm with extracorporeal shockwave lithotripsy in adult patients. | Urolithiasis | 2021 | https://conductscience.org/library/papers/32279108 | PubMed |
| 31606779 | Does the presence or degree of hydronephrosis affect the stone disintegration efficacy of extracorporeal shock wave lithotripsy? A systematic review and meta-analysis. | Urolithiasis | 2020 | https://conductscience.org/library/papers/31606779 | PubMed |
| 28792145 | Impact of Pretreatment Hydronephrosis on the Success Rate of Shock Wave Lithotripsy in Patients with Ureteral Stone. | Yonsei Med J | 2017 | https://conductscience.org/library/papers/28792145 | PubMed |
| 28348743 | Management of upper ureteral stones exceeding 15 mm in diameter: Shock wave lithotripsy versus semirigid ureteroscopy with holmium:yttrium-aluminum-garnet laser lithotripsy. | SAGE Open Med | 2016 | https://conductscience.org/library/papers/28348743 | PubMed |
| 23413950 | Recent finding and new technologies in nephrolitiasis: a review of the recent literature. | BMC Urol | 2013 | https://conductscience.org/library/papers/23413950 | PubMed |
| 19343443 | Extracorporeal shock wave lithotripsy as a first-line therapy for ureteral calculi with impaired renal function due to hydronephrosis. | Surg Endosc | 2009 | https://conductscience.org/library/papers/19343443 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17469029
GET https://conductscience.org/api/papers/v1/17469029/authors